Extensive-Stage Small-Cell Lung Cancer: Current Landscape and Future Prospects

por Saida, Yu, Watanabe, Satoshi, Kikuchi, Toshiaki
Publicado 2023

Editorial: Strategies to overcome tumor evasion and resistance to immunotherapies by targeting immune suppressor cells

por Saida, Yu, Watanabe, Satoshi, Koyama, Shohei, Togashi, Yosuke, Kikuchi, Toshiaki
Publicado 2023

PEGPH20, a PEGylated human hyaluronidase, induces radiosensitization by reoxygenation in pancreatic cancer xenografts. A molecular imaging study

por Seki, Tomohiro, Saida, Yu, Kishimoto, Shun, Lee, Jisook, Otowa, Yasunori, Yamamoto, Kazutoshi, Chandramouli, Gadisetti VR, Devasahayam, Nallathamby, Mitchell, James B., Krishna, Murali C., Brender, Jeffery R.
Publicado 2022

Prognostic significance of procalcitonin in small cell lung cancer

por Ichikawa, Kosuke, Watanabe, Satoshi, Miura, Satoru, Ohtsubo, Aya, Shoji, Satoshi, Nozaki, Koichiro, Tanaka, Tomohiro, Saida, Yu, Kondo, Rie, Hokari, Satoshi, Aoki, Nobumasa, Ohshima, Yasuyoshi, Koya, Toshiyuki, Kikuchi, Toshiaki
Publicado 2022

Efficacy and safety of amrubicin therapy after chemoimmunotherapy in small cell lung cancer patients

por Kushiro, Kohei, Watanabe, Satoshi, Goto, Yuka, Fujisaki, Toshiya, Yanagimura, Naohiro, Ohtsubo, Aya, Shoji, Satoshi, Nozaki, Koichiro, Tanaka, Tomohiro, Saida, Yu, Sato, Yusuke, Ota, Takeshi, Koshio, Jun, Hayashi, Yoshiki, Miyabayashi, Takao, Matsumoto, Naoya, Ichikawa, Kosuke, Koyama, Kenichi, Kikuchi, Toshiaki
Publicado 2022

Efficacy of EGFR‐TKIs with or without upfront brain radiotherapy for EGFR‐mutant NSCLC patients with central nervous system metastases

por Saida, Yu, Watanabe, Satoshi, Abe, Tetsuya, Shoji, Satoshi, Nozaki, Koichiro, Ichikawa, Kosuke, Kondo, Rie, Koyama, Kenichi, Miura, Satoru, Tanaka, Hiroshi, Okajima, Masaaki, Terada, Masaki, Ishida, Takashi, Tsukada, Hiroki, Makino, Masato, Iwashima, Akira, Sato, Kazuhiro, Matsumoto, Naoya, Yoshizawa, Hirohisa, Kikuchi, Toshiaki
Publicado 2019

Phase II study of nanoparticle albumin-bound paclitaxel monotherapy for relapsed non-small cell lung cancer with patient-reported outcomes (NLCTG1302)

por Shoji, Satoshi, Miura, Satoru, Watanabe, Satoshi, Ohtsubo, Aya, Nozaki, Koichiro, Saida, Yu, Ichikawa, Kosuke, Kondo, Rie, Tanaka, Tomohiro, Koyama, Kenichi, Tanaka, Hiroshi, Okajima, Masaaki, Abe, Tetsuya, Ota, Takeshi, Ishida, Takashi, Makino, Masato, Iwashima, Akira, Sato, Kazuhiro, Matsumoto, Naoya, Yoshizawa, Hirohisa, Kikuchi, Toshiaki
Publicado 2022

Transfer of in vitro-expanded naïve T cells after lymphodepletion enhances antitumor immunity through the induction of polyclonal antitumor effector T cells

por Tanaka, Tomohiro, Watanabe, Satoshi, Takahashi, Miho, Sato, Ko, Saida, Yu, Baba, Junko, Arita, Masashi, Sato, Miyuki, Ohtsubo, Aya, Shoji, Satoshi, Nozaki, Koichiro, Ichikawa, Kosuke, Kondo, Rie, Aoki, Nobumasa, Ohshima, Yasuyoshi, Sakagami, Takuro, Abe, Tetsuya, Moro, Hiroshi, Koya, Toshiyuki, Tanaka, Junta, Kagamu, Hiroshi, Yoshizawa, Hirohisa, Kikuchi, Toshiaki
Publicado 2017

Real-Time insight into in vivo redox status utilizing hyperpolarized [1-(13)C] N-acetyl cysteine

por Yamamoto, Kazutoshi, Opina, Ana, Sail, Deepak, Blackman, Burchelle, Saito, Keita, Brender, Jeffrey R., Malinowski, Ronja M., Seki, Tomohiro, Oshima, Nobu, Crooks, Daniel R., Kishimoto, Shun, Saida, Yu, Otowa, Yasunori, Choyke, Peter L., Ardenkjær-Larsen, Jan H., Mitchell, James B., Linehan, W. Marston, Swenson, Rolf E., Krishna, Murali C.
Publicado 2021

Phase II Trial of the Combination of Alectinib with Bevacizumab in Alectinib Refractory ALK-Positive Nonsquamous Non-Small-Cell Lung Cancer (NLCTG1501)

por Watanabe, Satoshi, Sakai, Kazuko, Matsumoto, Naoya, Koshio, Jun, Ishida, Akira, Abe, Tetsuya, Ishikawa, Daisuke, Tanaka, Tomohiro, Aoki, Ami, Kajiwara, Tomosue, Koyama, Kenichi, Miura, Satoru, Goto, Yuka, Sekiya, Tomoki, Suzuki, Ryo, Kushiro, Kohei, Fujisaki, Toshiya, Yanagimura, Naohiro, Ohtsubo, Aya, Shoji, Satoshi, Nozaki, Koichiro, Saida, Yu, Yoshizawa, Hirohisa, Nishio, Kazuto, Kikuchi, Toshiaki
Publicado 2022